News archivo - Page 3 of 20

6 March 2024

VIVEbiotech receives the EmakumeEkinn award for promoting innovation and female talent

On the occasion of the celebration of International Women's Day, the Sociedad Fomento San Sebastián has made today a recognition to women who contribute...

4 March 2024

Spanish researchers to design proteins using AI to make advanced therapies more efficient

The Ministry of Science, Innovation and Universities in collaboration with the Center for Technological Development and Innovation (CDTI) have selected it as one of the 40...

20 February 2024

Scrip Citeline Commercial reports VIVEbiotech’s predictions for 2024

At the end of 2023, Scrip Citeline Commercial gave us the opportunity to provide predictions for the year ahead.

14 February 2024

VIVEbiotech forecasts significant growth in lentiviral vectors and CAR-T therapies for 2024

Pharma Manufacturing asked Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, about her predictions on therapeutic advances for 2024.

13 February 2024

VIVEbiotech presents at a Gyrolab Technology Seminar

Bárbara Rodríguez-Urretavizcaya, Analytical Development Scientist at VIVEbiotech, will be presenting today at a Gyrolab Technology Seminar.

9 February 2024

VIVEbiotech participates in an article in Endpoints News about the challenges facing lentiviral vector production

VIVEbiotech participates in an article in Endpoints News about the challenges facing lentiviral vector production.

23 January 2024

Article resulting from a webinar in collaboration with Xpress Biologics, Polyplus, Sartorius

On November 28th VIVEbiotech participated in a webinar invited by Xpress Biologics, Polyplus, Sartorius.

23 January 2024

VIVEbiotech featured in an article in the Winter print issue of Drug Discovery World

Towards the end of last year, Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, was asked about her predictions for 2024 by the Drug Discovery World.